Description
GenJet™ DNA In Vitro
Transfection Reagent for WEHI-231 is pre-optimized for
transfecting WEHI-231 cells.
WEHI-231 is a murine B cell lymphoma that has been used extensively as a
model for the immature stage B cell and its functional response to Ag receptor
cross-linking as a model for immature B cell tolerance. This cell line expresses
sIgM, CD5, and FcR gamma, but lacks the B cell- specific isoform of CD45 (B220).
Refer to the following optimal transfection conditions for maximal transfection
efficiency on WEHI-231
cells. GenJet™ reagent, 1.0 ml, is sufficient for 300 to
600 transfections in 24 well plates or 50 to 100 transfections in 6 well plates.
|
Summary of
Optimal Transfection Conditions:
Confluence on the
day of transfection
Cell culture
conditions
GenJet™ (µl) : DNA (µg) Ratio
Diluent for DNA and Transfection Reagent
Incubation Time to Form GenJet™/DNA
Complex
Presence of Serum/Antibiotics
during Transfection
Change Medium After Transfection
Maximal Efficiency
Transfection
Results:
Reporter Gene
Plasmid
Efficiency (GFP %) |
~80%
DMEM with 4.5 g/L glucose, 10% FBS
3:1
1x GenJet™
Transfection Working Buffer
10 minutes at RT
Yes
Yes, ~5 Hours After Transfection
48 hours
EGFP
pEGFP-N3 (CMV promoter)
66% |
Storage Condition
Store at 4 °C. If stored properly, the product is stable for 12 months or longer
Data Sheet
